Skip to main content

Advertisement

Table 2 Unadjusted and adjusted ORs from logistic regression for association between statin prescription and subsequent diagnosis of depression between 2006-2008 ( n= 4,607,990)

From: Statin use and risk of depression: a Swedish national cohort study

  Unadjusted OR 95% CI p-value Age-adjusted OR 95% CI p-value Adjusted OR a 95% CI p-value
Statin prescriptions          
Any statin 0.92 0.89-0.96 <0.001 0.92 0.88-0.95 <0.001 0.95 0.91-0.99 0.016
Simvastatin 0.91 0.87-0.95 <0.001 0.91 0.87-0.94 <0.001 0.93 0.89-0.97 0.001
Pravastatin 0.86 0.71-1.04 0.120 0.85 0.70-1.03 0.090 0.90 0.74-1.09 0.268
Fluvastatin 0.92 0.61-1.37 0.677 0.91 0.61-1.36 0.643 0.98 0.65-1.46 0.914
Atorvastatin 1.02 0.93-1.13 0.632 1.03 0.94-0.97 0.507 1.11 1.01-1.22 0.032
Rosuvastatin 1.08 0.82-1.43 0.578 1.12 0.84-1.47 0.443 1.21 0.92-1.60 0.177
  1. CI = confidence interval; OR = odds ratio.
  2. aThe model includes prescription of statin medication (any statin, and by individual statins) and the following variables as covariates: gender, age (40-49, 50-59, 60-69, 70+), marital status, education (three levels), family income (quartiles), hospitalisation for cardio-pulmonary disease, hospitalisation for alcoholism, hospitalisation for coronary heart disease, and region (large cities, Southern, Northern).